1. Home
  2. VRME vs ADXN Comparison

VRME vs ADXN Comparison

Compare VRME & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VerifyMe Inc.

VRME

VerifyMe Inc.

HOLD

Current Price

$0.70

Market Cap

8.2M

Sector

Technology

ML Signal

HOLD

Logo Addex Therapeutics Ltd

ADXN

Addex Therapeutics Ltd

N/A

Current Price

$5.20

Market Cap

8.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VRME
ADXN
Founded
1999
2002
Country
United States
Switzerland
Employees
30
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
8.6M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
VRME
ADXN
Price
$0.70
$5.20
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$1.50
N/A
AVG Volume (30 Days)
36.8K
1.3K
Earning Date
05-13-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$36.85
$86.57
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.59
$5.41
52 Week High
$1.51
$12.05

Technical Indicators

Market Signals
Indicator
VRME
ADXN
Relative Strength Index (RSI) 57.09 49.71
Support Level $0.66 $5.98
Resistance Level $0.75 $7.37
Average True Range (ATR) 0.04 0.19
MACD 0.01 0.02
Stochastic Oscillator 72.91 47.37

Price Performance

Historical Comparison
VRME
ADXN

About VRME VerifyMe Inc.

VerifyMe Inc is a logistics company that specializes in time and temperature-sensitive products, as well as providing brand protection and enhancement solutions. The company operates through two reportable business segments: Precision Logistics offers a value-added service provider for time and temperature-sensitive parcel management. Using a proprietary IT platform, it provides real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries; and the Authentication segment specializes in anti-counterfeit and brand protection. The Precision Logistics segment derives the majority of the revenue.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: